DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Lindholm LH, Ibsen H, Borch-Johnsen K, Olsen MH, Wachtell K, Dahlöf B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristiansen K, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wedel H, Aurup P, Edelman JM, Snapinn S. for the LIFE study group.
Risk of new-onset diabetes in the losartan intervention for endpoint reduction
in hypertension study.
J Hypertens 2002;
20: 1879-1886
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.